These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1612756)

  • 1. Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle.
    Hodgson AL; Krywult J; Corner LA; Rothel JS; Radford AJ
    Infect Immun; 1992 Jul; 60(7):2900-5. PubMed ID: 1612756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.
    Hodgson AL; Tachedjian M; Corner LA; Radford AJ
    Infect Immun; 1994 Dec; 62(12):5275-80. PubMed ID: 7960105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A
    Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene expression in sheep following experimental infection with various strains of Corynebacterium pseudotuberculosis differing in virulence.
    Pépin M; Seow HF; Corner L; Rothel JS; Hodgson AL; Wood PR
    Vet Res; 1997; 28(2):149-63. PubMed ID: 9112737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
    Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene.
    Tachedjian M; Krywult J; Moore RJ; Hodgson AL
    Vaccine; 1995 Dec; 13(18):1785-92. PubMed ID: 8701594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain.
    Leal KS; de Oliveira Silva MT; de Fátima Silva Rezende A; Bezerra FSB; Begnini K; Seixas F; Collares T; Dellagostin O; Portela RW; de Carvalho Azevedo VA; Borsuk S
    Vaccine; 2018 Jun; 36(25):3578-3583. PubMed ID: 29759378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foreign gene expression in Corynebacterium pseudotuberculosis: development of a live vaccine vector.
    Moore RJ; Rothel L; Krywult J; Radford AJ; Lund K; Hodgson AL
    Vaccine; 1999 Oct; 18(5-6):487-97. PubMed ID: 10519938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis.
    Fontaine MC; Baird G; Connor KM; Rudge K; Sales J; Donachie W
    Vaccine; 2006 Aug; 24(33-34):5986-96. PubMed ID: 16806606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis.
    McNamara PJ; Bradley GA; Songer JG
    Mol Microbiol; 1994 Jun; 12(6):921-30. PubMed ID: 7934899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.
    Simmons CP; Dunstan SJ; Tachedjian M; Krywult J; Hodgson AL; Strugnell RA
    Infect Immun; 1998 Feb; 66(2):474-9. PubMed ID: 9453598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.
    Chaplin PJ; De Rose R; Boyle JS; McWaters P; Kelly J; Tennent JM; Lew AM; Scheerlinck JP
    Infect Immun; 1999 Dec; 67(12):6434-8. PubMed ID: 10569760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.
    Ribeiro D; Rocha Fde S; Leite KM; Soares Sde C; Silva A; Portela RW; Meyer R; Miyoshi A; Oliveira SC; Azevedo V; Dorella FA
    Vet Res; 2014 Mar; 45(1):28. PubMed ID: 24597857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A description of genes of Corynebacterium pseudotuberculosis useful in diagnostics and vaccine applications.
    D'Afonseca V; Moraes PM; Dorella FA; Pacheco LG; Meyer R; Portela RW; Miyoshi A; Azevedo V
    Genet Mol Res; 2008 Mar; 7(1):252-60. PubMed ID: 18551390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of an enzymatically inactive analog of phospholipase D from Corynebacterium pseudotuberculosis.
    Haynes JA; Tkalcevic J; Nisbet IT
    Gene; 1992 Sep; 119(1):119-21. PubMed ID: 1398078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of phospholipase D, the major virulence factor of Corynebacterium pseudotuberculosis, is regulated by multiple environmental factors and plays a role in macrophage death.
    McKean SC; Davies JK; Moore RJ
    Microbiology (Reading); 2007 Jul; 153(Pt 7):2203-2211. PubMed ID: 17600064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Approach of B and T Cell Epitopes of PLD and CP40 Proteins of
    Rodríguez-Domínguez MC; Montes-de-Oca-Jiménez R; Vázquez-Chagoyán JC; Rivadeneira-Barreiro PE; Zambrano-Rodríguez PC; Ruiz-Riva-Palacio ME; Gutiérrez-Castillo ADC; de-Castro-Soares S; Vieyra-Reyes P; Arteaga-Troncoso G
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens.
    El-Enbaawy MI; Saad MM; Selim SA
    Egypt J Immunol; 2005; 12(2):13-9. PubMed ID: 17977206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new Corynebacterium pseudotuberculosis antigens by immunoscreening of gene expression library.
    Galvão CE; Fragoso SP; de Oliveira CE; Forner O; Pereira RRB; Soares CO; Rosinha GMS
    BMC Microbiol; 2017 Sep; 17(1):202. PubMed ID: 28934943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D-neutralization in serodiagnosis of Arcanobacterium haemolyticum and Corynebacterium pseudotuberculosis infections.
    Skalka B; Literák I; Chalupa P; Votava M
    Zentralbl Bakteriol; 1998 Dec; 288(4):463-70. PubMed ID: 9987184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.